在动脉样硬化中,NAD代谢调节巨细胞的增殖
Satyesh K Sinha1,2,3, Chantle R Swichkow1,2,3, Lia Farahi1,2,3
1Department of Medicine/Division of Cardiology (S.K.S., C.R.S., L.F., M.P., C.P., Z.Z., J.J.M., R.C.D., D.M.S., A.J.L.), University of California Los Angeles.
Arteriosclerosis, thrombosis, and vascular biology
|September 11, 2025
概括
尼古丁胺 N-甲基转移酶 (NNMT) 通过改变巨细胞中的尼古丁胺腺素二核酸 (NAD) 水平来驱动动动脉硬化. 抑制NNMT或促进NAD代谢可以减少病变的发生,并改善巨细胞的功能.
科学领域:
- 心血管研究研究心血管研究
- 代谢性疾病 代谢性疾病
- 分子遗传学 分子遗传学
背景情况:
- 之前已经确定了与动脉样硬化相关的染色体9位点.
- 现在已经确定NNMT (尼古丁胺胺N-甲基转移酶) 是病因基因.
- 这种机制涉及尼古丁胺的恢复到尼古丁胺胺二核酸 (NAD).
研究的目的:
- 研究NAD水平在巨细胞增殖和动脉样硬化中的亡中的作用.
- 为了确定NNMT抑制是否影响动脉样硬化进展.
主要方法:
- 在巨细胞的功能研究中获得/损失.
- 全球NNMT抑制使用反感性寡核酸.
- 使用siRNA在肝脏和脂肪中选择性NNMT抑制.
- 从NNmt淘汰赛小鼠移植骨髓.
- 对巨细胞CD38表达的分析.
- 来自异构卵性NNmt淘汰赛小鼠的巨细胞培养.
主要成果:
- 全球NNMT抑制显著减少了小鼠的动脉样硬化病变区域.
- 选择性NNMT抑制在肝脏/脂肪细胞的效果是最小的.
- 来自Nnmt淘汰赛小鼠的骨髓减少了病变巨细胞的增殖和增加了亡.
- 减少CD38表达减少了巨细胞的增殖和动脉样硬化.
- 来自Nnmt淘汰赛小鼠的巨体显示出减少的增殖,增加的亡,以及更高的NAD/NADH比率.
结论:
- 尼古丁胺的挽救和NAD的周转对于巨细胞的增殖和动脉样硬化中的生存至关重要.
- 在巨细胞中,NNMT在调节NAD代谢方面发挥着关键作用.
- 准NNMT或NAD代谢是一种潜在的动脉样硬化治疗策略.
更多相关视频
07:45Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis
Published on: November 28, 2015
36.5K
09:57Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
10.1K
相关概念视频
Inflammation
61.7K
Overview
61.7K
Regulation of Metabolism
11.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.4K
Atherosclerosis I: Introduction
933
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
933
